CenterWatch

Clinical Trial Details

Overview

Research Study Summary

Do You Have Rheumatoid Arthritis? Osteoporosis or Osteopenia? Research Study 20101324

Purpose

Currently, a clinical research study is under way to evaluate the effectiveness of an investigational medication. We are looking for participants who have Rheumatoid Arthritis and either Osteoporosis or Osteopenia (or both). If you have been diagnosed as described above, you may be eligible to participate in this clinical research study.

Qualified participants will receive study related medication, examinations and care. Other eligibility criteria will apply. Compensation for time and travel.

To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.

You may qualify to participate if you:

  • Are a postmenopausal woman between 45 and 80 years old
  • Currently taking Enbrel (for at least six months)
  • Have a confirmed diagnosis of Rheumatoid Arthritis and either Osteoporosis or Osteopenia (or both)

Patient Exclusion Criteria:
If you do not fall within the age range, are not currently taking Enbrel, and/or do not have Rheumatoid Arthritis along with either Osteoporosis or Osteopenia (or both).

To Learn more

CW ID:182220
Date Last Changed: July 18, 2013

Clinical Trial Snapshot

Phase
1
Gender
Female
Age
45 to 80 Years
Overall Status
Recruiting
Facility Type
N/A

Contact

Metroplex Clinical Research Center
8144 Walnut Hill Lane Suite 810
Dallas, TX 75231
Phone: 214-424-0405

View Map

Research Center Information: Metroplex Clinical Research Center

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.